BRIEF published on 07/19/2024 at 09:55, 1 year 4 months ago Sartorius Stedim Biotech SA: Provision of financial documents Financial Results Investors Sartorius Stedim Biotech First Half Of 2024 Documents Available
PRESS RELEASE published on 07/19/2024 at 09:51, 1 year 4 months ago Sartorius Stedim Biotech SA: Communiqué de mise à disposition de documents Communicado sobre los resultados del primer semestre de 2024 del grupo Sartorius Stedim Biotech disponibles para los inversores Sartorius Stedim Biotech 2024 Resultados Inversionistas Primer Semestre
PRESS RELEASE published on 07/19/2024 at 09:51, 1 year 4 months ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech Group releases first-half 2024 results report with business development and financial statements. Leading biopharmaceutical partner based in Aubagne, France Financial Statements Biopharmaceutical Industry Sartorius Stedim Biotech Group First-half 2024 Results Aubagne
PRESS RELEASE published on 07/19/2024 at 09:50, 1 year 4 months ago Sartorius Stedim Biotech SA: Communiqué de mise à disposition de documents Le communiqué de mise à disposition de documents du groupe Sartorius Stedim Biotech pour les résultats du premier semestre 2024 est disponible, incluant le développement des affaires et les comptes consolidés Sartorius Stedim Biotech Résultats Comptes Consolidés Investisseurs Semestre 2024
PRESS RELEASE published on 07/19/2024 at 09:50, 1 year 4 months ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech SA releases information on the availability of documents, including first half 2024 results and financial statements Financial Results Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry Document Availability
PRESS RELEASE published on 07/19/2024 at 09:39, 1 year 4 months ago Half yearly financial reports and audit reports/limited reviews
PRESS RELEASE published on 07/19/2024 at 09:37, 1 year 4 months ago Half yearly financial reports and audit reports/limited reviews
PRESS RELEASE published on 07/18/2024 at 18:30, 1 year 4 months ago Half-year results 2024 of SartoriusStedimBiotech Sartorius Stedim Biotech reports half-year results for 2024 with sales revenue of 1,373 million euros and a cautious outlook for the year ahead due to market volatility Volatility Sartorius Stedim Biotech Sales Revenue Outlook Half-year Results
PRESS RELEASE published on 07/18/2024 at 18:30, 1 year 4 months ago Résultats de Sartorius Stedim Biotech pour le premier semestre 2024 Résultats semestriels de Sartorius Stedim Biotech avec chiffre d’affaires en baisse organique de 3,8%, EBITDA à 387 millions d’euros et perspectives prudentes pour 2024 Chiffre D'affaires Résultats Semestriels EBITDA Sartorius Stedim Biotech Perspectives 2024
BRIEF published on 07/18/2024 at 18:26, 1 year 4 months ago Sartorius Stedim Biotech Updates Guidance and Shares H1 2024 Results Financial Results Sartorius Stedim Biotech H1 2024 Fiscal Guidance Life Science Sector
Published on 12/05/2025 at 23:30, 9 minutes ago 55 North Mining Inc. Announces Completion of Third and Final Tranche of Private Placement for a Total of $4,202,000
Published on 12/05/2025 at 21:45, 1 hour 54 minutes ago When the Architecture Becomes Visible: The SMX Revaluation Explained
Published on 12/05/2025 at 21:30, 2 hours 9 minutes ago The Identity Layer Beneath Everything: Why Markets Are Revaluing SMX All at Once
Published on 12/05/2025 at 21:20, 2 hours 19 minutes ago Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement
Published on 12/05/2025 at 22:15, 1 hour 23 minutes ago CPI PROPERTY GROUP - Changes in Shareholding and Board of Directors
Published on 12/05/2025 at 22:12, 1 hour 26 minutes ago EQS-Adhoc: CPI PROPERTY GROUP - Change to Distribution Policy
Published on 12/05/2025 at 18:58, 4 hours 40 minutes ago EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:15, 5 hours 23 minutes ago Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 23:00, 39 minutes ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 39 minutes ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 12/05/2025 at 23:00, 39 minutes ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 23:00, 39 minutes ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES NOVEMBRE 2025
Published on 12/05/2025 at 17:18, 6 hours 21 minutes ago La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
